News

Articles and press releases

JAL Therapeutics Presents at First Look SoCal Innovation Showcase

Leave a Comment / News /

June 4, 2024- JAL Therapeutics presented at the First Look SoCal Innovation Showcase, held at the Skirball Cultural Center in Los Angeles. The event, organized by the Alliance for Southern California Innovation, provided a valuable platform for startups in life sciences, biotech, and technology across the region. It was a perfect opportunity for our team […]

JAL Therapeutics Presents at First Look SoCal Innovation Showcase Read More »

JAL Therapeutics joins Academic Venture Exchange

Leave a Comment / Uncategorized /

March 1, 2024– JAL Therapeutics, a pioneering life sciences company focused on developing innovative treatments for Alzheimer’s disease and other chronic conditions, has joined the Academic Venture Exchange (AVX). As a non-profit cooperative, AVX plays a crucial role in connecting groundbreaking, IP-backed ventures with the investment community, facilitating the growth and impact of scientific and

JAL Therapeutics joins Academic Venture Exchange Read More »

Alzheimer’s Drug Developer, JAL Therapeutics, Selected Into California Life Sciences, FAST Advisory Program

Leave a Comment / News /

JAL Therapeutics’ highly inhibitory, hyperselective, covalent approach to butyrylcholinesterase (BChE) inhibition may become the new frontier for treating and preventing Alzheimer’s disease, CNS disorders and other chronic conditions.

Alzheimer’s Drug Developer, JAL Therapeutics, Selected Into California Life Sciences, FAST Advisory Program Read More »

JAL Therapeutics Presents Alzheimer’s Drug Candidate at Octane’s Medical Innovation Forum

Leave a Comment / Uncategorized /

October 8, 2022—JAL Therapeutics presented at the Octane Medical Innovation Forum, sharing company progress on its lead drug candidate. Octane is a convening organization of the technology and medical technology communities of Southern California. At the forum, the company presented its goals for future innovation, including the exploration of treatments being pursued by JAL Therapeutics

JAL Therapeutics Presents Alzheimer’s Drug Candidate at Octane’s Medical Innovation Forum Read More »

Developing potential treatments for Alzheimer’s disease, neurodegenerative disorders and other chronic conditions.​ 

Linkedin

© 2023 All Rights Reserved

18201 McDurmott West
Suite A​
Irvine, CA 92614​

(949) 247-3250

© 2023 All Rights Reserved

18201 McDurmott West
Suite A
Irvine, CA 92614

(949) 247-3250

Scroll to Top